|
GB201600401D0
|
|
Propafenone medicine intermediates 3-(a-ethyl)-4-hydroxycoumarin synthesis method
|
|
GB201600405D0
|
|
Methoxy kanamycin medicine intermediate y-amino -a- hydroxybutyric acid synthesis method
|
|
GB201600400D0
|
|
Riboflavin medicine intermediate 3,4-dimethylaniline synthesis method
|
|
GB201600404D0
|
|
Medicine intermediate 2,4-thiocyante-nitrophenyl ester synthesis method
|
|
GB201600402D0
|
|
Amorolfine medicine intermediate of tert-amyl bromide sythesis method
|
|
GB201600399D0
|
|
Uraidil medicine intermediate 1,3-dimethyl-6-(3-hydroxy-propyl) amino uracil synthesis method
|
|
GB201600403D0
|
|
Buckley triazine medicine intermediate 4-tert-butyl benzyl chloride synthesis method
|
|
GB201600335D0
|
|
Propafenone medicine intermediate benzyl malonate terephthalate synthesis method
|
|
GB201600324D0
|
|
VPA medicine intermediate two methyl propyl cyanide synthesis method
|
|
GB201600327D0
|
|
Allyl Nigeria given medicine intermediate 2-(N-allyl--N-2,6- dichlorophenyl)amino imidazoline synthesis method
|
|
GB201600333D0
|
|
Astemizole medicine intermediate N-(4- fluorobenzyl)phthalimide synthesis method
|
|
GB201600321D0
|
|
Bis-triazine medicine intermediate3-chloro-3,4,5-trimethoxy benzoate, propyl synthesis method
|
|
GB201600330D0
|
|
Fluconazole medicine intermediate 2,4-dichloro-a-(1H-1,2,4- triazol-1-yl) acetophenone synthesis method
|
|
GB201600207D0
|
|
Bevantolol pharmaceutical intermediate 3-between toluene-1,2-oxide synthesis method
|
|
GB201600200D0
|
|
0-ethoxy benzamide medicine intermediate o-ethoxy benzoate synthesis method
|
|
GB201600206D0
|
|
FD-2 anticancer medicine intermediate compound 2-n-butoxy-5-amino-pyrimidin-4-oe synthesis method
|
|
GB201600218D0
|
|
Pentoxyverine medicine intermediate1-phenyl-cyclopentane carboxylic acid synthesis method
|
|
GB201600193D0
|
|
Tranilast medicine intermediate3,4-dimethoxybenzaldehyde synthesis method
|
|
GB201600196D0
|
|
Gastrodin medicine intermediate4-formylphenyl-2,3,4,6-tetra-0-acetyl-P-D-glucopyranoside synthesis method
|
|
GB201600203D0
|
|
Fluorouracil medicine intermediate 1-benzyl-5-amino uracil phthalocyanine synthesis method
|
